The purpose of this study is to recruit a total of 386 participants to evaluate the effectiveness of an educational program to increase the proportion of men and women aged 21 years and older who have received the COVID-19 booster vaccine
This study will address vaccine hesitancy, evaluating the intervention's efficacy in a group of vulnerable and economically disadvantaged population in PR. Randomized Clinical Trial (study design) to evaluate the effectiveness of an educational intervention to increase vaccine uptake among socioeconomically disadvantaged adults. A total sample of 386 participants will be recruited. The duration of the study will consist of 1.5 hours for intervention group and 1 hour for control group. Eligibility criteria for the study include the following: (1) age 21 years and older, (2) resident of Puerto Rico, (3) to be fully vaccinated (received the one-dose Jansen/Johnson \& Johnson vaccine, -OR- received both doses of the two-dose Pfizer or Moderna vaccine), have not received booster doses against COVID-19, (4) no history of allergic reactions to any vaccine, (5) no history of mental health conditions that impede participation in the study, and (6) able to read, write, and understand Spanish.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Enrollment
394
Randomized Clinical Trial (study design) to evaluate the effectiveness of an educational intervention to increase vaccine uptake among socioeconomically disadvantaged adults. The intervention will consist of a health promoter with an educational toolkit addressing misinformation, distrust, and hesitancy regarding the COVID-19 vaccine. An educational website with videos addressing COVID-19 vaccine will be available to study participants to boost information provided in the educational toolkit.
Outpatient Clinic, School of Medicine, University of Puerto Rico
San Juan, Puerto Rico
University District Hospital
San Juan, Puerto Rico
Rate of COVID-19 vaccine completion
The investigators will record the vaccine brand of primary (Pfizer, Moderna, or Johnson \& Johnson) and capture the vaccine administration's completion (if necessary).
Time frame: Up to 4 months
Rate of COVID-10 booster vaccine uptake
The investigators will capture the booster vaccine administration and record the vaccine brand (Pfizer, Moderna, or Johnson \& Johnson).
Time frame: Up to 4 months
Participant's willingness to get vaccinated against COVID-19
Willingness to vaccinate against COVID-19 (vaccine confidence, vaccine convenience, vaccine complacency, and vaccine attitudes and beliefs), and receive the physician's recommendation to be vaccinated
Time frame: Up to 4 months
Educational tool utilization by the participants
Evaluate if participant read the educational tool
Time frame: Up to 4 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.